Founded in 1980, Hydromer, Inc. is a long-established and highly recognized medical device coating company in the United States. With over 40 years of technical heritage, extensive clinical validation experience, and advanced cleanroom facilities, Hydromer has earned the trust of major global medical device companies under the leadership of its current CEO, Mike Torti, and has become an ideal partner for new R&D projects. The company has built a long-term and solid foundation of trust in the high-end medical device industry in the U.S. and around the world, and is widely recognized for its strong compliance capabilities, reliability, and professional standards.
Singapore-based jMedtech has officially become a strategic shareholder of Hydromer to jointly build a future-oriented global medical device coating platform. This platform integrates UV curing and thermal curing coating systems, supported by advanced coating equipment and regional OEM capabilities, providing global customers with a comprehensive solution covering R&D, validation, and mass production.
This move not only amplifies Hydromer’s technological and brand influence, but also marks a key step in jMedtech’s global layout. Through the collaboration with Hydromer, jMedtech connects the capability synergy between Asia and the Americas, forming a mirrored delivery network covering major medical device markets, and creating greater value for customers in terms of supply chain resilience and market response speed.
jMedtech is fully accelerating its globalization process. With its Singapore headquarters as the strategic hub, it links the dual engines of the Americas and Asia to build a trustworthy, efficient, and future-leading integrated platform for medical coatings and medical tubing for global customers.
